President
CSE
Dalhousie University
Sharon Mulvagh MD FRCPC FACC FASE FAHA
Dr. Mulvagh is Professor of Medicine at Dalhousie University, Halifax, Nova Scotia Canada, Professor Emeritus at Mayo Clinic, Rochester, MN, USA, and President of the Canadian Society of Echocardiography.
Dr. Mulvagh is a clinical cardiologist, echocardiographer, and clinician investigator for multiple Federal (CIHR-Canadian Institute of Health Research) and Foundation (Heart and Stroke Canada; Dalhousie University) funded research projects in Canada and USA focused on women and heart disease, contrast echocardiography, and POCUS. She is Co-Director of the Women’s Heart Health Clinic at the Maritime Heart Center in Halifax, NS, Past-Chair of the Nova Scotia Provincial Board of Directors for Heart & Stroke Canada, Immediate Past-Chair of Canadian Women's Heart Health Alliance, Knowledge Translation and Mobilization Working Group, Past-Chair of American Society of Echocardiography (ASE) Scientific Sessions, current member of National Board of Echocardiography (NBE) Critical Care Echocardiography Exam Writing Committee, and NBE Certification Committees, past member of ASE Board of Directors and current member of International Contrast Ultrasound Society Board of Directors. She has chaired numerous echocardiographic guidelines imaging task forces and committees, including the initial consensus statement and subsequent guidelines and updates on Ultrasound Enhancing Agents. She has over 180 peer reviewed publications, and is on the editorial boards of Canadian Journal of Cardiology, Journal of the American Society of Echocardiography, and Journal of the American College of Cardiology.
Dr. Mulvagh received her medical degree, magna cum laude, from University of Ottawa, Canada, interned at Dalhousie University, then completed her residency at Boston University, and cardiology fellowship at Baylor College of Medicine in Houston, TX. There, she consulted for Universities Space Research Associates (USRA) at NASA, Johnson Space Center, monitoring cardiac responses during spacewalks from Mission Control, training astronauts to do echocardiograms during spaceflight and developing countermeasures to microgravity.
Disclosure(s): Novo Nordisk: Steering Committee for SOUL Clinical Trial (Ongoing)
203 - ADVANCES IN PULMONARY HYPERTENSION – ENHANCING CARE THROUGH INNOVATION AND COLLABORATION
Friday, October 25, 2024
12:30 PM – 1:30 PM PT
325 - IMAGING THE THICK HEART: A MULTIMODALITY APPROACH
Saturday, October 26, 2024
9:45 AM – 10:45 AM PT
344 - CSE SPOTLIGHT: RETHINKING THE AORTIC VALVE, A NEW APPROACH TO A COMMON PROBLEM
Saturday, October 26, 2024
2:00 PM – 3:00 PM PT